Pfizer has slammed the extended powers allowing the EU to block exports of its vaccines and claims the move has 'caused a significant administrative burden' to the rollout of the vaccine . The drug company's vice-president for global supply, Danny Hendrikse, described how the EU's export controls, which were introduced in February, had affected the production of its vaccine and created 'some uncertainty' on the free movement of its goods ...